EDETATE CALCIUM DISODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Edetate Calcium Disodium patents expire, and what generic alternatives are available?
Edetate Calcium Disodium is a drug marketed by Casper Pharma Llc and is included in one NDA.
The generic ingredient in EDETATE CALCIUM DISODIUM is edetate calcium disodium. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the edetate calcium disodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Edetate Calcium Disodium
A generic version of EDETATE CALCIUM DISODIUM was approved as edetate calcium disodium by CASPER PHARMA LLC on May 3rd, 2023.
Summary for EDETATE CALCIUM DISODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 156 |
| Clinical Trials: | 4 |
| Patent Applications: | 649 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | EDETATE CALCIUM DISODIUM at DailyMed |
Recent Clinical Trials for EDETATE CALCIUM DISODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
| Mt. Sinai Medical Center, Miami | Phase 4 |
Pharmacology for EDETATE CALCIUM DISODIUM
| Drug Class | Anti-coagulant Lead Chelator |
| Mechanism of Action | Calcium Chelating Activity Lead Chelating Activity |
| Physiological Effect | Decreased Coagulation Factor Activity |
US Patents and Regulatory Information for EDETATE CALCIUM DISODIUM
EDETATE CALCIUM DISODIUM is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting EDETATE CALCIUM DISODIUM
COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | EDETATE CALCIUM DISODIUM | edetate calcium disodium | INJECTABLE;INJECTION | 216435-001 | May 3, 2023 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
